Samer Tabchi

486 total citations
24 papers, 326 citations indexed

About

Samer Tabchi is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Samer Tabchi has authored 24 papers receiving a total of 326 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Oncology, 10 papers in Pulmonary and Respiratory Medicine and 4 papers in Molecular Biology. Recurrent topics in Samer Tabchi's work include Lung Cancer Treatments and Mutations (8 papers), Lung Cancer Research Studies (6 papers) and Colorectal Cancer Treatments and Studies (5 papers). Samer Tabchi is often cited by papers focused on Lung Cancer Treatments and Mutations (8 papers), Lung Cancer Research Studies (6 papers) and Colorectal Cancer Treatments and Studies (5 papers). Samer Tabchi collaborates with scholars based in Lebanon, Canada and Belgium. Samer Tabchi's co-authors include Normand Blais, Hampig Raphaël Kourié, Mustapha Tehfé, Marwan Ghosn, Xiaoduan Weng, Elie Rassy, Joseph Kattan, Marie‐Pierre Campeau, Marie Florescu and Jocelyne Martin and has published in prestigious journals such as World Journal of Gastroenterology, Quality of Life Research and Frontiers in Oncology.

In The Last Decade

Samer Tabchi

23 papers receiving 322 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Samer Tabchi Lebanon 12 214 141 66 33 28 24 326
Michael J. Grant United States 7 179 0.8× 134 1.0× 47 0.7× 39 1.2× 34 1.2× 15 284
Valeria Stati Italy 11 182 0.9× 99 0.7× 61 0.9× 27 0.8× 27 1.0× 25 319
Vishal Navani Canada 11 205 1.0× 172 1.2× 87 1.3× 49 1.5× 42 1.5× 38 338
Humera Khurshid United States 11 190 0.9× 137 1.0× 70 1.1× 41 1.2× 23 0.8× 24 342
M. Guirado Spain 9 202 0.9× 254 1.8× 54 0.8× 37 1.1× 15 0.5× 24 361
Elena Collovà Italy 8 155 0.7× 140 1.0× 45 0.7× 46 1.4× 44 1.6× 23 352
Valérie Cristina Switzerland 7 175 0.8× 101 0.7× 70 1.1× 35 1.1× 34 1.2× 15 364
Yoko Fukuda Japan 9 79 0.4× 120 0.9× 49 0.7× 30 0.9× 26 0.9× 17 233
Giuseppe Giaccone United States 10 321 1.5× 164 1.2× 63 1.0× 30 0.9× 61 2.2× 17 434
Richard Mansour United States 9 152 0.7× 71 0.5× 40 0.6× 38 1.2× 34 1.2× 56 326

Countries citing papers authored by Samer Tabchi

Since Specialization
Citations

This map shows the geographic impact of Samer Tabchi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Samer Tabchi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Samer Tabchi more than expected).

Fields of papers citing papers by Samer Tabchi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Samer Tabchi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Samer Tabchi. The network helps show where Samer Tabchi may publish in the future.

Co-authorship network of co-authors of Samer Tabchi

This figure shows the co-authorship network connecting the top 25 collaborators of Samer Tabchi. A scholar is included among the top collaborators of Samer Tabchi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Samer Tabchi. Samer Tabchi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Desîlets, Antoine, Wiam Belkaïd, Julie Malo, et al.. (2024). CRYOVATE: A Pilot Study of Lung Cancer Cryoactivation in Combination With Immunotherapy in Advanced NSCLC. JTO Clinical and Research Reports. 5(12). 100737–100737. 2 indexed citations
2.
Tabchi, Samer, Krina K. Patel, Hans C. Lee, et al.. (2019). Retrospective Review of the Use of High-Dose Cyclophosphamide, Bortezomib, Doxorubicin, and Dexamethasone for the Treatment of Multiple Myeloma and Plasma Cell Leukemia. Clinical Lymphoma Myeloma & Leukemia. 19(9). 560–569. 19 indexed citations
3.
Assi, Tarek, Joseph Kattan, Elie Rassy, et al.. (2018). Efficacy and safety of everolimus in hormone receptor positive breast cancer in a developing country: Real-life single institutional experience. Journal of Cancer Research and Therapeutics. 14(5). 1112–1116. 2 indexed citations
4.
Tehfé, Mustapha, Samer Tabchi, Maria Maddalena Laterza, & Ferdinando De Vita. (2018). Ramucirumab in Her-2-Positive Gastroesophageal Adenocarcinoma: An Argument for Overcoming Trastuzumab Resistance. Future Oncology. 14(3). 223–228. 6 indexed citations
5.
Tabchi, Samer, Normand Blais, Marie‐Pierre Campeau, & Mustapha Tehfé. (2017). Single-center comparison of multiple chemotherapy regimens for concurrent chemoradiotherapy in unresectable stage III non-small-cell lung cancer. Cancer Chemotherapy and Pharmacology. 79(2). 381–387. 8 indexed citations
6.
Tabchi, Samer & Normand Blais. (2017). Antiangiogenesis for Advanced Non-Small-Cell Lung Cancer in the Era of Immunotherapy and Personalized Medicine. Frontiers in Oncology. 7. 52–52. 24 indexed citations
7.
Tabchi, Samer, Elie Rassy, Hampig Raphaël Kourié, et al.. (2017). Management of stage III non–small cell lung cancer. Seminars in Oncology. 44(3). 163–177. 37 indexed citations
8.
Tabchi, Samer, et al.. (2017). Factors Influencing Treatment Selection and Survival in Advanced Lung Cancer. Current Oncology. 24(2). 115–122. 23 indexed citations
9.
Ghosn, Marwan, Samer Tabchi, Hampig Raphaël Kourié, & Mustapha Tehfé. (2016). Metastatic gastric cancer treatment: Second line and beyond. World Journal of Gastroenterology. 22(11). 3069–3069. 27 indexed citations
10.
Tabchi, Samer, Xiaoduan Weng, & Normand Blais. (2016). Severe agranulocytosis in a patient with metastatic non-small-cell lung cancer treated with nivolumab. Lung Cancer. 99. 123–126. 38 indexed citations
11.
Tabchi, Samer, et al.. (2016). Anti-EGFR Therapy for Metastatic Colorectal Cancer in the Era of Extended RAS Gene Mutational Analysis. BioDrugs. 30(2). 95–104. 5 indexed citations
12.
Tabchi, Samer, Hampig Raphaël Kourié, & Joseph Kattan. (2016). Adding checkpoint inhibitors to tyrosine kinase inhibitors targeting EGFR/ALK in non-small cell lung cancer: a new therapeutic strategy. Investigational New Drugs. 34(6). 794–796. 15 indexed citations
13.
Tabchi, Samer, Hampig Raphaël Kourié, & Jean Klášterský. (2016). Concurrent driver mutations/rearrangements in non-small-cell lung cancer. Current Opinion in Oncology. 29(2). 118–122. 12 indexed citations
14.
Assi, Tarek, Elie Rassy, Samer Tabchi, et al.. (2015). Treatment of cancer patients in their last month of life: aimless chemotherapy. Supportive Care in Cancer. 24(4). 1603–1608. 24 indexed citations
15.
Rassy, Elie, Samer Tabchi, Fadi Haddad, et al.. (2015). Acquired factor inhibitor in a patient with monoclonal gammopathy of undetermined significance responding to rituximab. Blood Coagulation & Fibrinolysis. 27(7). 822–824.
16.
Tabchi, Samer, Elie Rassy, Fadi El Karak, et al.. (2015). Validation of the EORTC QLQ-INFO 25 questionnaire in Lebanese cancer patients: Is ignorance a Bliss?. Quality of Life Research. 25(6). 1597–1604. 12 indexed citations
17.
Karak, Fadi El, et al.. (2015). BRAFV600 mutant non-small-cell lung cancer resistant to Vemurafenib.. PubMed. 8(3). 3294–8. 2 indexed citations
18.
Tabchi, Samer, et al.. (2014). Successful treatment of Evans syndrome with Tacrolimus. Investigational New Drugs. 33(1). 254–256. 3 indexed citations
19.
Tabchi, Samer & Marwan Ghosn. (2014). Regorafenib: start low and go slow. Targeted Oncology. 10(3). 445–447. 19 indexed citations
20.
Tabchi, Samer, et al.. (2012). Prévalence du jeu pathologique chez les étudiants libanais. L Encéphale. 39(1). 1–5. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Michael J. Grant Breakdown of academic impact, for papers by Valeria Stati Breakdown of academic impact, for papers by Vishal Navani Breakdown of academic impact, for papers by Humera Khurshid Breakdown of academic impact, for papers by M. Guirado Breakdown of academic impact, for papers by Elena Collovà Breakdown of academic impact, for papers by Valérie Cristina Breakdown of academic impact, for papers by Yoko Fukuda Breakdown of academic impact, for papers by Giuseppe Giaccone Breakdown of academic impact, for papers by Richard Mansour
Rankless by CCL
2026